Recent Finacing
Recent Raise
Invasight develops protein–protein interaction antagonists to inhibit cancer cell invasion and uses its ACINDA platform—3D tumoroid plates, invasion models, ML automated cell dissemination counter, CADD, and digital biobank.
Focus Areas
Recent Investors
Funding round
Investors
